Rare and unusual case of anti-factor XI antibodies in patient with plasma cell leukemia
ConclusionBoth PCL and anti-factor XI inhibitors are two very rare entities. To the best of our knowledge, this is the first reported case of a factor XI inhibitor arising in the setting of PCL. Factor inhibitors should be suspected in patients whose monoclonal gammopathies are accompanied by bleeding manifestations.
Source: BMC Hematology - Category: Hematology Source Type: research
More News: Anemia | Bleeding | Dexamethasone | Hematology | Leukemia | Lupus | Normocytic Normochromic Anemia | Papanicolaou (Pap) Smear | Proteinuria | Thrombocytopenia | Urology & Nephrology | Velcade